Elicio Therapeutics Inc. (ELTX)
Healthcare
Biotechnology
2.90 $
+2.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Elicio Therapeutics Inc. (ELTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 46.9% of the shares are freely tradable; institutional investors hold 17.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
17.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
29.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
46.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
9.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
26Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Knoll Capital Management LP | 2.40 | 630,915 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.97 | 518,638 | +0.0 | 03/31/2026 |
| Balyasny Asset Management LLC | 0.93 | 244,814 | +76.4 | 03/31/2026 |
| Geode Capital Management, LLC | 0.51 | 135,164 | +2.0 | 03/31/2026 |
| Renaissance Technologies Corp | 0.46 | 121,631 | +332.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 1.58 | 415,401 | +8.0 | 06/30/2026 |
| iShares Russell 2000 ETF | 1.21 | 317,361 | -0.1 | 07/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.55 | 143,596 | +13.8 | 06/30/2026 |
| iShares Russell 2000 Growth ETF | 0.46 | 119,835 | -0.1 | 07/30/2026 |
| Russell 2000 Index Non-Lendable Fund | 0.40 | 104,699 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.